Federal cannabis reform medical implications extend beyond policy headlines to real clinical practice considerations. Healthcare providers and patients must navigate evolving regulations while maintaining focus on evidence-based medical cannabis care. Understanding the distinction between rescheduling and clinical practice changes helps inform realistic expectations during this transition period.